139 related articles for article (PubMed ID: 12506025)
21. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins.
Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
J Cell Sci; 2009 Apr; 122(Pt 8):1201-10. PubMed ID: 19339552
[TBL] [Abstract][Full Text] [Related]
22. Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules.
Bocchia M; Wentworth PA; Southwood S; Sidney J; McGraw K; Scheinberg DA; Sette A
Blood; 1995 May; 85(10):2680-4. PubMed ID: 7742526
[TBL] [Abstract][Full Text] [Related]
23. PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.
Crowder C; Dahle Ø; Davis RE; Gabrielsen OS; Rudikoff S
Blood; 2005 Feb; 105(3):1280-7. PubMed ID: 15459016
[TBL] [Abstract][Full Text] [Related]
24. The molecular biology of acute promyelocytic leukemia.
Slack JL; Gallagher RE
Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
[TBL] [Abstract][Full Text] [Related]
25. Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies.
Fabunmi RP; Wigley WC; Thomas PJ; DeMartino GN
J Cell Sci; 2001 Jan; 114(Pt 1):29-36. PubMed ID: 11112687
[TBL] [Abstract][Full Text] [Related]
26. Proto-oncogene PML enhances antigen presentation by MHC class I molecules in human lung cancer cells.
Chang SK; Park B; Shin J; Ahn JH; Kim IH; Ahn K
Mol Cells; 2002 Aug; 14(1):130-5. PubMed ID: 12243342
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML.
Borden KL; Lally JM; Martin SR; O'Reilly NJ; Solomon E; Freemont PS
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1601-6. PubMed ID: 8643677
[TBL] [Abstract][Full Text] [Related]
28. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
[TBL] [Abstract][Full Text] [Related]
29. The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies.
Ruthardt M; Orleth A; Tomassoni L; Puccetti E; Riganelli D; Alcalay M; Mannucci R; Nicoletti I; Grignani F; Fagioli M; Pelicci PG
Oncogene; 1998 Apr; 16(15):1945-53. PubMed ID: 9591778
[TBL] [Abstract][Full Text] [Related]
30. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
31. PML promotes MHC class II gene expression by stabilizing the class II transactivator.
Ulbricht T; Alzrigat M; Horch A; Reuter N; von Mikecz A; Steimle V; Schmitt E; Krämer OH; Stamminger T; Hemmerich P
J Cell Biol; 2012 Oct; 199(1):49-63. PubMed ID: 23007646
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor-8b-stimulated myogenic cell proliferation is suppressed by the promyelocytic leukemia gene.
Kwong WH; Tang MK; Yew DT; Chan JY; Cai DQ; Tong WM; Lee KK
Biol Signals Recept; 2001; 10(5):285-93. PubMed ID: 11490093
[TBL] [Abstract][Full Text] [Related]
33. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.
Lallemand-Breitenbach V; Zhu J; Puvion F; Koken M; Honoré N; Doubeikovsky A; Duprez E; Pandolfi PP; Puvion E; Freemont P; de Thé H
J Exp Med; 2001 Jun; 193(12):1361-71. PubMed ID: 11413191
[TBL] [Abstract][Full Text] [Related]
34. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
35. Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation.
Cabrera CM; Jiménez P; Concha A; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2004 May; 63(5):446-52. PubMed ID: 15104675
[TBL] [Abstract][Full Text] [Related]
36. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
[TBL] [Abstract][Full Text] [Related]
37. Immediate early gene X1 (IEX-1) is organized in subnuclear structures and partially co-localizes with promyelocytic leukemia protein in HeLa cells.
Kruse ML; Arlt A; Sieke A; Grohmann F; Grossmann M; Minkenberg J; Fölsch UR; Schäfer H
J Biol Chem; 2005 Jul; 280(26):24849-56. PubMed ID: 15855159
[TBL] [Abstract][Full Text] [Related]
38. Deconstructing PML-induced premature senescence.
Bischof O; Kirsh O; Pearson M; Itahana K; Pelicci PG; Dejean A
EMBO J; 2002 Jul; 21(13):3358-69. PubMed ID: 12093737
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies.
Block GJ; Eskiw CH; Dellaire G; Bazett-Jones DP
Mol Cell Biol; 2006 Dec; 26(23):8814-25. PubMed ID: 16966371
[TBL] [Abstract][Full Text] [Related]
40. The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage.
Salomoni P; Bernardi R; Bergmann S; Changou A; Tuttle S; Pandolfi PP
Blood; 2005 May; 105(9):3686-90. PubMed ID: 15626733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
